CSIMarket
 
Kazia Therapeutics Limited  (NASDAQ: KZIA)
 

Kazia Therapeutics Limited's Customers Performance

KZIA



 
KZIA's Source of Revenues During the corresponding time, Kazia Therapeutics Limited saw a revenue deteriorated by -98.31 % year on year, While revenue at the Kazia Therapeutics Limited's corporate clients

List of KZIA Customers




for the same period Kazia Therapeutics Limited revnue deteriorated by -98.31 % year on year,

List of KZIA Customers

Kazia Therapeutics Limited's Business Units
Sale of paxalisib    100 % of total Revenue
Sale of paxalisib Timing of revenue recognition    100 % of total Revenue
Israel    100 % of total Revenue






Kazia Therapeutics Limited's Comment on Sales, Marketing and Customers



The company provides services to financial institutions seeking immediate liquidity and identifies risks associated with liquidity constraints and funding access that may affect its operations. It also focuses on strategic collaborations within the biotechnology and pharmaceutical sectors, including an exclusive collaboration and in-licensing agreement with QIMR Berghofer Medical Research Institute for a PD-L1 degrader program in cancer immunotherapy.





Kazia Therapeutics Limited’s Comment on Sales, Marketing and Customers


The company provides services to financial institutions seeking immediate liquidity and identifies risks associated with liquidity constraints and funding access that may affect its operations. It also focuses on strategic collaborations within the biotechnology and pharmaceutical sectors, including an exclusive collaboration and in-licensing agreement with QIMR Berghofer Medical Research Institute for a PD-L1 degrader program in cancer immunotherapy.








KZIA's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Kazia Therapeutics Limited 5,591.74 0.04 -20.70 47
SUBTOTAL 0.00 0.00 0.00 -

Sources: Kazia Therapeutics Limited’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Kazia Therapeutics Limited’s corporate clients.
For your research, we’ve provided 9 tables on Kazia Therapeutics Limited corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.